Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prokidney (PROK) EBITDA Margin: 2022-2025

Historic EBITDA Margin for Prokidney (PROK) over the last 4 years, with Sep 2025 value amounting to -17,759.91%.

  • Prokidney's EBITDA Margin fell 246640991.00% to -17,759.91% in Q3 2025 from the same period last year, while for Sep 2025 it was -23,011.69%, marking a year-over-year decrease of 158616169.00%. This contributed to the annual value of -241,678.95% for FY2024, which is 150436228.00% down from last year.
  • Per Prokidney's latest filing, its EBITDA Margin stood at -17,759.91% for Q3 2025, which was up 1.16% from -17,967.87% recorded in Q2 2025.
  • In the past 5 years, Prokidney's EBITDA Margin registered a high of 2,448,650.00% during Q3 2024, and its lowest value of -67,856.58% during Q4 2024.
  • In the last 3 years, Prokidney's EBITDA Margin had a median value of 995,475.00% in 2023 and averaged 1,023,811.74%.
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 220,818,793bps in 2023, then plummeted by 246,640,991bps in 2025.
  • Prokidney's EBITDA Margin (Quarterly) stood at 1,511,750.00% in 2022, then slumped by 70,475,000bps to 807,000.00% in 2023, then plummeted by 87,485,658bps to -67,856.58% in 2024, then tumbled by 246,640,991bps to -17,759.91% in 2025.
  • Its last three reported values are -17,759.91% in Q3 2025, -17,967.87% for Q2 2025, and -17,994.78% during Q1 2025.